Table 1

Schedule of evaluation of the NCVC-CS1 feasibility study

	Entry	Treatment	3 days	30 days	90 days	180 days
Inclusion/exclusion criteria	X
Signed consent form	X
Provisional enrolment	X
Medical/treatment history*	X
Neurological assessment	X		X	X	X	X
mRS score	X			X	X	X
Laboratory tests†	X
CTA/MRA‡	X				X
Medication§	X	X	X	X	X	X
Cerebral angiography¶		X				X
Final enrolment		X
Endovascular procedure**		X
Adverse events		X	X	X	X	X

*History of cerebrovascular diseases, neurosurgical treatments, cerebral endovascular treatments, hypertension, dyslipidemia, diabetes mellitus and so on.
†Haematology, biochemistry and coagulation.
‡Location, size, form, maximum diameter, neck diameter and parent artery diameter of the target aneurysm.
§Antiplatelets, anticoagulants and medications for complications.
¶Location, size, form, maximum diameter, neck width and parent artery diameter of the target aneurysm.
**Site of puncture, anaesthesia and medical devices used in the procedure.
CTA, CT angiography, MRA, magnetic resonance angiography; mRS, modified Rankin scale.